name:-2.4971051216125
name:-0.3653199672699
name:-0.28075098991394
ZORA BIOSCIENCES OY Patent Filings

ZORA BIOSCIENCES OY

Patent Applications and Registrations

Patent applications and USPTO patent grants for ZORA BIOSCIENCES OY.The latest application filed is for "ceramides and their use in diagnosing cvd".

Company Profile
13.35.34
  • ZORA BIOSCIENCES OY - ESPOO FI
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Trademarks
Patent Activity
PatentDate
Ceramides And Their Use In Diagnosing Cvd
App 20220163547 - Laaksonen; Reijo
2022-05-26
Biomarkers For Cardiovascular Events
App 20220003791 - HILVO; Mika ;   et al.
2022-01-06
Methods For Detecting Ovarian Cancer
App 20210405054 - HILVO; Mika
2021-12-30
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients
App 20210239719 - Laaksonen; Reijo ;   et al.
2021-08-05
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
Grant 10,955,427 - Laaksonen , et al. March 23, 2
2021-03-23
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease
App 20210003598 - Laaksonen; Reijo ;   et al.
2021-01-07
Methods For Prediction And Early Detection Of Diabetes
App 20200348316 - HUYNH; Kevin ;   et al.
2020-11-05
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
Grant 10,551,394 - Laaksonen , et al. Fe
2020-02-04
Methods for detecting ovarian cancer
Grant 10,534,001 - Hilvo Ja
2020-01-14
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients
App 20200003794 - Laaksonen; Reijo ;   et al.
2020-01-02
Ceramides And Their Use In Diagnosing Cvd
App 20190113531 - Laaksonen; Reijo
2019-04-18
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
Grant 10,261,101 - Laaksonen , et al.
2019-04-16
USE OF CERAMIDES AND LPLs IN DIAGNOSING CVD
App 20190086386 - Sysi-Aho; Marko ;   et al.
2019-03-21
Ceramides and their use in diagnosing CVD
Grant 10,197,582 - Laaksonen Fe
2019-02-05
Use of ceramides and LPLs in diagnosing CVD
Grant 10,184,932 - Hilvo , et al. Ja
2019-01-22
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease
App 20180321266 - Laaksonen; Reijo ;   et al.
2018-11-08
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients
App 20180067138 - Laaksonen; Reijo ;   et al.
2018-03-08
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
Grant 9,863,965 - Laaksonen , et al. January 9, 2
2018-01-09
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
Grant 9,857,386 - Laaksonen , et al. January 2, 2
2018-01-02
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
Grant 9,841,431 - Laaksonen , et al. December 12, 2
2017-12-12
Methods For Detecting Ovarian Cancer
App 20170285036 - Hilvo; Mika
2017-10-05
USE OF CERAMIDES AND LPLs IN DIAGNOSING CVD
App 20170160264 - Sysi-Aho; Marko ;   et al.
2017-06-08
Biomarkers for sensitive detection of statin-induced muscle toxicity
Grant 9,664,698 - Laaksonen , et al. May 30, 2
2017-05-30
Biomarkers For Sensitive Detection Of Statin-induced Muscle Toxicity
App 20170082644 - Laaksonen; Reijo ;   et al.
2017-03-23
Biomarkers for sensitive detection of statin-induced muscle toxicity
Grant 9,541,565 - Laaksonen , et al. January 10, 2
2017-01-10
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease
App 20160363601 - Laaksonen; Reijo ;   et al.
2016-12-15
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Undergoing Statin Treatment
App 20160363602 - Laaksonen; Reijo ;   et al.
2016-12-15
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Not Undergoing Statin Treatment
App 20160320418 - Laaksonen; Reijo ;   et al.
2016-11-03
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
Grant 9,459,264 - Laaksonen , et al. October 4, 2
2016-10-04
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
Grant 9,459,265 - Laaksonen , et al. October 4, 2
2016-10-04
Ceramides And Their Use In Diagnosing Cvd
App 20160266152 - Laaksonen; Reijo
2016-09-15
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
Grant 9,423,406 - Laaksonen , et al. August 23, 2
2016-08-23
Sensitive Efficacy and Specificity Biomarkers for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition
App 20160146842 - Laaksonen; Reijo
2016-05-26
Ceramides and their use in diagnosing CVD
Grant 9,347,960 - Laaksonen May 24, 2
2016-05-24
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients
App 20160025751 - Laaksonen; Reijo ;   et al.
2016-01-28
Non-high Density Lipoprotein Derived Cvd Markers
App 20160018423 - Laaksonen; Reijo
2016-01-21
Ceramides And Their Use In Diagnosing Cvd
App 20150362513 - Laaksonen; Reijo
2015-12-17
Lipidomic biomarkers for identification of high-risk coronary artery disease patients
Grant 9,201,080 - Laaksonen , et al. December 1, 2
2015-12-01
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Undergoing Statin Treatment
App 20150260738 - Laaksonen; Reijo ;   et al.
2015-09-17
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Not Undergoing Statin Treatment
App 20150260737 - Laaksonen; Reijo ;   et al.
2015-09-17
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease
App 20150247873 - LAAKSONEN; Reijo ;   et al.
2015-09-03
Sensitive Efficacy and Specificity Biomarkers for Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Inhibition
App 20150160247 - Laaksonen; Reijo
2015-06-11
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients not undergoing statin treatment
Grant 9,052,328 - Laaksonen , et al. June 9, 2
2015-06-09
Lipidomic biomarkers for the prediction of cardiovascular outcomes in coronary artery disease patients undergoing statin treatment
Grant 9,052,327 - Laaksonen , et al. June 9, 2
2015-06-09
Lipidomic biomarkers for atherosclerosis and cardiovascular disease
Grant 9,046,538 - Laaksonen , et al. June 2, 2
2015-06-02
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Undergoing Statin Treatment
App 20140295466 - Laaksonen; Reijo ;   et al.
2014-10-02
Lipidomic Biomarkers For The Prediction Of Cardiovascular Outcomes In Coronary Artery Disease Patients Not Undergoing Statin Treatment
App 20140295467 - Laaksonen; Reijo ;   et al.
2014-10-02
Biomarkers for Sensitive Detection of Statin-Induced Muscle Toxicity
App 20140031332 - Laaksonen; Reijo ;   et al.
2014-01-30
Lipidomic Biomarkers for Identification of High-Risk Coronary Artery Disease Patients
App 20130216560 - Laaksonen; Reijo ;   et al.
2013-08-22
Lipidomic Biomarkers For Atherosclerosis And Cardiovascular Disease
App 20130045217 - Laaksonen; Reijo ;   et al.
2013-02-21
Biomarkers For Sensitive Detection Of Statin-induced Muscle Toxicity
App 20120258123 - Laaksonen; Reijo ;   et al.
2012-10-11
Biofluid Metabolite Profiling As A Tool For Early Prediction Of Autoimmunity And Type 1 Diabetes Risk
App 20090318392 - Oresic; Matej ;   et al.
2009-12-24
Diagnostic method for myopathy
Grant 7,611,902 - Laaksonen , et al. November 3, 2
2009-11-03
Company Registrations

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed